Maryland, 17 April 2024: The FDA slammed three Indian drugmakers with Form 483s following recent inspections that uncovered unsanitary conditions, broken equipment and poor recordkeeping.

 

Mumbai-based Alkem Labs was cited with  View Details

Related News

• Sugar content in Cerelac lower than FSSAI limit: Nestle (30-04-2024)

---

• US FDA approves First Drug Indicated in Patients with WHIM Syndrome (30-04-2024)

---

• Four-fold rise in immunodeficiency cases in seven years (30-04-2024)

---

• Drug firms told to set up system for 'prompt' recalls (30-04-2024)

---

• Amendments to tighten law on misleading drug ads stalled since 2020 (30-04-2024)

---

• Patanjali Group firms under DGGI scanner for non-payment of GST, fake ITC (30-04-2024)

---

• US FDA tightens scrutiny of lab-developed tests with new rule (30-04-2024)

---

• Uttarakhand suspends permissions of 14 products of Ramdev's pharma firms (30-04-2024)

---

• No jewellery, cellphone use in ICU: Advisory to health workers (29-04-2024)

---

• Indian industry should focus on business risk mitigation initiatives to grab global opportunities: DoP study (29-04-2024)

---